James L. Tyree, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 48,130 shares at $56.62 ($2.7M) on 2007-06-01, disclosed to the SEC on 2007-06-05.
Scheduled sale ($2.7M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.62 | 13,333 | $755K | 27.7% |
| 2 | $56.62 | 34,797 | $2.0M | 72.3% |
| Total | $56.62 avg | 48,130 | $2.7M | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |